Jamie Dananberg's most recent trade in Annexon Inc was a trade of 5,820 Common Stock done at an average price of $5.4 . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.43 per share. | 02 Mar 2026 | 5,820 | 123,582 | - | 5.4 | 31,603 | Common Stock |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 56,250 | 129,402 | - | 0 | Common Stock | |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.10 per share. | 18 Feb 2026 | 5,290 | 73,152 | - | 5.1 | 26,979 | Common Stock |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 228,225 | 228,225 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 78,442 | - | 0 | Common Stock | |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.96 per share. | 18 Feb 2025 | 5,521 | 33,479 | - | 3.0 | 16,342 | Common Stock |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Jamie Dananberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 39,000 | - | 0 | Common Stock | |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 31 Mar 2023 | 420 | 62,817 (0%) | 0% | 1.7 | 714 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 14 Mar 2023 | 1,005 | 63,237 (0%) | 0% | 4 | 4,020 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.84 per share. | 02 Feb 2023 | 863 | 64,242 (0%) | 0% | 4.8 | 4,177 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.85 per share. | 14 Dec 2022 | 1,016 | 65,105 (0%) | 0% | 2.9 | 2,896 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.48 per share. | 14 Sep 2022 | 10,923 | 661,213 (1%) | 0% | 0.5 | 5,243 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 27 Jun 2022 | 4,398 | 672,136 (1%) | 0% | 0.6 | 2,595 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 21 Jun 2022 | 3,697 | 676,534 (1%) | 0% | 0.6 | 2,292 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. | 14 Jun 2022 | 10,530 | 680,231 (1%) | 0% | 0.6 | 6,634 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 31 Mar 2022 | 4,188 | 690,761 (1%) | 0% | 1.1 | 4,774 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.88 per share. | 14 Mar 2022 | 10,581 | 694,949 (1%) | 0% | 0.9 | 9,311 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 183,333 | 183,333 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 45,833 | 705,530 (1%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Unity Biotechnology Inc | Jamie Dananberg | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 14 Dec 2021 | 10,614 | 659,697 (1%) | 0% | 1.6 | 17,301 | Common Stock, $0.0001 par value |